Company / Revenue per Share
Supernus Pharmaceuticals, Inc. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$12.90
FY2025
5-year range
$10.94 / $12.90
FY2021-FY2025
Trend
+6.6%
vs FY2024
Sector context
#40 of 154
Health Care
What the data says
At $12.90, Supernus Pharmaceuticals, Inc.'s revenue per share ranks #40 of 154 in the Health Care sector. Revenue per Share has fluctuated over the past 10 years, ranging from $1.63 in FY2019 to $12.90 in FY2025.
Based on SEC 10-K filings.
12.90 in FY2025 with a 5-year CAGR of +5.4%.
Improved from $10.94 to $12.90 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
#40 of 154 in Health CareTop 26% of 154This company $12.90 Sector average $15.09
▼
-14.5% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 6.6% year-over-year.
- Ranks #40 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.90 | +6.6% |
| FY2024 | $12.09 | +10.5% |
| FY2023 | $10.94 | -12.6% |
| FY2022 | $12.53 | +14.2% |
| FY2021 | $10.97 | +10.7% |
| FY2020 | $9.91 | +506.3% |
| FY2019 | $1.63 | -61.0% |
| FY2018 | $4.19 | +42.0% |
| FY2017 | $2.95 | +56.0% |
| FY2016 | $1.89 | -44.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026